Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04780698 · ClinicalTrials.gov registry record · NA
DCI COVID-19 Surveillance Project
A NA study of Covid19, sponsored by Temple University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04780698 is a NA study of Covid19 that has completed, run by Temple University. The registered enrollment target is 30 participants, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04780698, a NA study of Covid19, has completed, sponsored by Temple University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective longitudinal census study conducted at a single center (DCI Inc., Henry Avenue, Philadelphia). The purpose of this study is to gain information about COVID-19 infection and antibody response in an in-center dialysis population. The investigators hypothesize that screening and surveillance for COVID-19 positive test (viral infection) and antibodies response to infection (potential immunity) in a dialysis center population within a high-prevalence region can provide foundational information to guide approaches toward prevention of COVID-19 related illness in a susceptible population. Participants will be given a questionnaire initially and monthly over the study period to find out whether they have had COVID-19 infection, hospitalization, or symptoms. A nasopharyngeal swab test for COVID-19 infection and a blood sample for COVID-19 antibody will be collected monthly for the study period.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection
Study Locations (1)
Pennsylvania
- Dialysis Clinic, Inc. - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-02-12 |
| Est. Completion | 2022-10-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04780698
The ClinicalTrials.gov registry entry for NCT04780698 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,702-participant average among 94 other Covid19 trials with a reported enrollment target (99% lower). The listed sponsor is Temple University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 appearing as the primary indexed condition, and to 1 intervention - of which SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection is the first listed.
NCT04780698 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04780698 about?
NCT04780698 is a clinical study titled "DCI COVID-19 Surveillance Project". This is a prospective longitudinal census study conducted at a single center (DCI Inc., Henry Avenue, Philadelphia). The purpose of this study is to gain information about COVID-19 infection and antibody response in an in-center dialysis population. The investigators hypothesize that screening and s...
What is the current status of trial NCT04780698?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-02-12. Estimated completion is 2022-10-13.
What conditions does trial NCT04780698 study?
This clinical trial studies the following conditions: Covid19.
What interventions are being tested in trial NCT04780698?
The interventions under investigation include: SARS-CoV-2 RT-PCR Assay for Detection of COVID-19 Infection (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04780698?
This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04780698 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Covid19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Multimodal Parent-focused Intervention for Vulnerable Populations in the Bronx
RECRUITING · NA
-
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
ACTIVE NOT RECRUITING · NA
-
Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs
ACTIVE NOT RECRUITING · NA
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
COMPLETED · NA
-
Implementation of COVID-19 Testing Strategies in Community Health Centers
COMPLETED · NA
-
Minnesota COVID-19 Testing Project
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.